TAO Synergies TAOX
NASDAQ TAOX
$4.12 +0.11 (+2.74%)
As of: Sep 9, 2026 · 12:29 PM EDT

TAO Synergies (TAOX) Treasury Shares (2020 - 2026)

TAO Synergies' (TAOX) quarterly Treasury Shares came in at $11000.0 in Q2 2026, up 100.0% on a YoY basis from $5500.0 in Q2 2025, and little changed quarter-over-quarter from $11000.0 in Q1 2026.

Analysis

TAO Synergies (TAOX) Treasury Shares (2020 - 2026) Analysis & Trends

TAO Synergies (TAOX) has reported Treasury Shares for 6 consecutive years, with $11000.0 the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Treasury Shares rose 100.0% year-over-year to $11000.0; the trailing twelve-month figure through Jun 2026 stood at $11000.0 (up 100.0% YoY), and the FY2025 full-year result was $11000.0, up 156.71% from the prior year.
  • Treasury Shares steadied at $11000.0 in Q2 2026 per TAOX's latest filing, from $11000.0 in the prior quarter.
  • Across five years, Treasury Shares topped out at $6.8 million in Q3 2022 and bottomed at $1204.0 in Q3 2025.
  • Historically, Treasury Shares has averaged $496480.6 across 5 years, with a median of $10000.0 in 2023.
  • The sharpest annual moves came in 2023 and 2026: Treasury Shares tumbled 99.87% in 2023, then soared 208.12% in 2026.
  • Over 5 years, Treasury Shares stood at $15000.0 in 2022, then plunged by 60.0% to $6000.0 in 2023, then slipped by 28.58% to $4285.0 in 2024, then jumped by 156.71% to $11000.0 in 2025, then changed by 0.0% to $11000.0 in 2026.
  • According to Business Quant data, Treasury Shares over the past three periods registered $11000.0, $11000.0, and $11000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Treasury Shares (Qtr)
1 Amgen 211.63 Bn 197.64 Bn 7.24 Bn -
2 Gilead Sciences 181.39 Bn 178.21 Bn 6.22 Bn -
3 Vertex Pharmaceuticals 132.32 Bn 124.47 Bn 2.84 Bn -
4 Regeneron Pharmaceuticals 82.47 Bn 74.47 Bn 3.93 Bn 36.40 Mn
5 Argenx Se 61.52 Bn 56.34 Bn 1.37 Bn -
6 Moderna 54.79 Bn 49.65 Bn 52.00 Mn -
7 Alnylam Pharmaceuticals 34.04 Bn 30.73 Bn 992.69 Mn -
8 Biogen 31.39 Bn 30.11 Bn 1.96 Bn -23.80 Mn
9 Roivant Sciences 30.09 Bn 30.09 Bn 1.16 Mn -
10 TAO Synergies 30.93 Mn 30.93 Mn - 11,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 11,000.00
Jun 30, 2026 11,000.00
Mar 31, 2026 11,000.00
Mar 31, 2026 11,000.00
Dec 31, 2025 11,000.00
Dec 31, 2025 11,000.00
Sep 30, 2025 1,204.00
Sep 30, 2025 1,204.00
Jun 30, 2025 5,500.00
Jun 30, 2025 5,500.00
Mar 31, 2025 3,570.00
Mar 31, 2025 3,570.00
Dec 31, 2024 4,285.00
Dec 31, 2024 4,285.00
Mar 31, 2024 3,000.00
Mar 31, 2024 3,000.00
Dec 31, 2023 6,000.00
Dec 31, 2023 6,000.00
Sep 30, 2023 9,000.00
Sep 30, 2023 9,000.00